Shubhshree Biofuels Energy Ltd
Established in 2013, Shubhshree Biofuels Energy Limited supplies biomass fuels such as biomass pellets and briquettes to customers in sectors like recycled materials, textile processing, pharmaceuticals, and metals.[1]
- Market Cap ₹ 174 Cr.
- Current Price ₹ 331
- High / Low ₹ 495 / 274
- Stock P/E 16.5
- Book Value ₹ 77.8
- Dividend Yield 0.00 %
- ROCE 32.6 %
- ROE 29.6 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Products Other Industrial Products
Part of Nifty SME Emerge
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 163 | 202 | |
| 152 | 187 | |
| Operating Profit | 11 | 15 |
| OPM % | 7% | 7% |
| 1 | 1 | |
| Interest | 0 | 1 |
| Depreciation | 0 | 0 |
| Profit before tax | 11 | 14 |
| Tax % | 24% | 21% |
| 8 | 11 | |
| EPS in Rs | 15.43 | 20.09 |
| Dividend Payout % | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 30% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 5 | 5 |
| Reserves | 25 | 36 |
| 8 | 13 | |
| 12 | 16 | |
| Total Liabilities | 51 | 70 |
| 3 | 6 | |
| CWIP | 0 | 0 |
| Investments | 5 | 1 |
| 42 | 63 | |
| Total Assets | 51 | 70 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| -9 | -1 | |
| -6 | -4 | |
| 22 | 4 | |
| Net Cash Flow | 8 | -1 |
| Free Cash Flow | -11 | -5 |
| CFO/OP | -58% | 3% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 59 | 69 |
| Inventory Days | 12 | 17 |
| Days Payable | 32 | 27 |
| Cash Conversion Cycle | 39 | 59 |
| Working Capital Days | 28 | 40 |
| ROCE % | 33% |
Insights
In beta| Mar 2025 | Mar 2026 | Mar 2027 (P) | |
|---|---|---|---|
| Installed Manufacturing Capacity TPD |
|
||
| Number of Operational Plants count |
|||
| Capacity Utilization % |
|||
| Cumulative Tonnage Supplied to Customers tonnes |
|||
| Number of Clients Served count |
|||
| Number of States Covered count |
|||
| Annual Tonnage Sold (Biomass Fuels) tonnes |
|||
| Number of Village Level Entrepreneurs (VLEs) count |
|||
Extracted by Screener AI
Documents
Announcements
-
Structural Digital Database
10 July 2026 - SDD compliance certificate for quarter ended June 30, 2026; one event captured, no non-compliances.
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
9 July 2026 - NSE Emerge SME company says Q1 FY27 corporate governance report not applicable; PCS certificate attached.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
9 July 2026 - Submitted Regulation 74(5) certificate for quarter ended June 30, 2026; no rematerialisation requests received.
-
Analysts/Institutional Investor Meet/Con. Call Updates
3 June 2026 - FY26 call: revenue INR202 crore, FY27 capex INR15-20 crore, capacity to 1,000 TPD, torrefaction plant by Jul/Aug 2026.
-
Analysts/Institutional Investor Meet/Con. Call Updates
1 June 2026 - Audio recording shared for June 1, 2026 investor call on FY26 audited standalone and consolidated results.
Business Profile[1] The company manufactures and supplies biomass fuels, including pellets and briquettes, as an eco-friendly alternative to fossil fuels. These fuels serve industries like recycling, textiles, and pharmaceuticals, sourced from both in-house production and external vendors.